Open AccessMinimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study
Author(s) -
Megan E.B. Clowse,
Frauke Förger,
Caroline Hwang,
John Thorp,
Radboud J E M Dolhain,
Astrid van Tubergen,
Laura Shaughnessy,
Jeff Simpson,
Marie Teil,
Nathalie Toublanc,
Maggie Wang,
Thomas W. Hale
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/hhyp-7t13
Subject(s) - certolizumab pegol , pharmacokinetics , medicine , postmarketing surveillance , medical physics , pharmacology , adverse effect , rheumatoid arthritis , etanercept